Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Airway Nerve Block vs Nebulized Lidocaine for Awake Fiberoptic Intubation
NCT07627100Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine (2 arms), sponsored by Mayo Clinic. Primary endpoints: Mean Arterial Pressure Change at 5 months and Heart Rate Change at 5 months. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NCT07627100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07627100.